Analyst Upgrades – Core Laboratories (NYSE:CLB) Stock Gets Upgraded By Loop Capital from Hold to Buy

12

Analyst Ratings For Core Laboratories (NYSE:CLB)

Today, Core Laboratories (NYSE:CLB) stock received an upgrade by Loop Capital from Hold to Buy.

There are 3 sell ratings, 8 hold ratings, 3 buy ratings on the stock.

The current consensus rating on Core Laboratories (NYSE:CLB) is Hold (Score: 2.00) with a consensus target price of $124.45 per share, a potential 9.65% upside.

Some recent analyst ratings include

  • 4/21/2017-Loop Capital Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 3/23/2017-Tudor Pickering initiated coverage with a Hold rating.
  • 3/11/2017-Citigroup Inc Reiterated Rating of Neutral.
  • 12/7/2016-Stephens was Downgraded by analysts at Stephens from a “Equal Weight ” rating to a ” Sell” rating. They now have a $91.00 price target on the stock.
  • 12/6/2016-Guggenheim was Downgraded by analysts at Guggenheim from a “Buy ” rating to a ” Neutral” rating.
  • 10/22/2016-Cowen and Company Reiterated Rating of Market Perform.

Dividend information for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE:CLB) pays an annual dividend of $2.20 with a yield of 1.94% and an average dividend growth of 19.80% based on a 3 Year Average..

Dividend History for Core Laboratories (NYSE:CLB)

  • On 4/19/2017 Core Laboratories announced a quarterly dividend of $0.55 1.98% with an ex dividend date of 4/27/2017 which will be payable on 5/23/2017.
  • On 1/10/2017 Core Laboratories announced a Quarterly dividend of $0.55 1.8% with an ex dividend date of 1/18/2017 which will be payable on 2/17/2017.
  • On 10/11/2016 Core Laboratories announced a Quarterly dividend of $0.55 1.95% with an ex dividend date of 10/19/2016 which will be payable on 11/22/2016.
  • On 7/7/2016 Core Laboratories announced a Quarterly dividend of $0.55 with an ex dividend date of 7/14/2016 which will be payable on 8/15/2016.
  • On 4/15/2016 Core Laboratories announced a Quarterly dividend of $0.55 with an ex dividend date of 5/2/2016 which will be payable on 5/24/2016.
  • On 1/11/2016 Core Laboratories announced a Quarterly dividend of $0.55 2.28% with an ex dividend date of 1/20/2016 which will be payable on 2/19/2016.
  • On 10/13/2015 Core Laboratories announced a Quarterly dividend of $0.55 with an ex dividend date of 10/21/2015 which will be payable on 11/24/2015.


  • On 2/1/2017 Michael Straughen, Director, bought 106 with an average share price of $118.65 per share and the total transaction amounting to $12,576.90. View SEC Filing
  • On 1/30/2017 Martha Z Carnes, Director, bought 200 with an average share price of $115.20 per share and the total transaction amounting to $23,040.00. View SEC Filing
  • On 2/2/2016 Jan Willem Sodderland, Director, bought 300 with an average share price of $93.90 per share and the total transaction amounting to $28,170.00. View SEC Filing
  • On 5/12/2015 Michael C Kearney, Director, sold 1,000 with an average share price of $128.52 per share and the total transaction amounting to $128,520.00. View SEC Filing
  • On 11/17/2014 Mark F Elvig, VP, sold 1,000 with an average share price of $138.03 per share and the total transaction amounting to $138,030.00. View SEC Filing
  • On 7/28/2014 Richard L Bergmark, CFO, bought 7,000 with an average share price of $147.31 per share and the total transaction amounting to $1,031,170.00. View SEC Filing
  • On 3/7/2014 Michael Kearney, Director, sold 2,000 with an average share price of $193.00 per share and the total transaction amounting to $386,000.00. View SEC Filing

About Core Laboratories (NYSE:CLB)
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients’ reservoirs.

Recent Trading Activity for Core Laboratories (NYSE:CLB)
Shares of Core Laboratories closed the previous trading session at 113.50 up +2.39 2.15% with 1,027,206 shares trading hands.

An ad to help with our costs